Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they propose to take to support women with long-term health conditions.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The health of women with long-term conditions is a priority for the Government.
Our 10-Year Health Plan is centred around driving three shifts in the way health care is delivered, from hospital to community, from analogue to digital, and from sickness to prevention. More tests and scans are delivered in the community, better-joint up working between services, and greater use of technology will support women in the management of long-term conditions. This will build on the work led by the pioneering women’s health hubs.
The Government is encouraging integrated care boards (ICBs) to expand the coverage of women’s health hubs and is supporting them to use what we learned from the hub pilot programme to improve local delivery of services to women and girls. The Government is backing ICBs to do this through record funding.
We are renewing the Women’s Health Strategy, to tackle enduring challenges and build on vital progress in women’s health.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they intend to take to prevent any increase in the number of women performing dangerous late-term abortions at home.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Parliament decided in 2022 to amend the Abortion Act 1967 to make home use of medical abortion pills a permanent option in England and Wales where the pregnancy has not exceeded 10 weeks gestation. Before pills are prescribed for an early medical abortion at home, the woman requesting the abortion will have had a consultation with a clinician either in person, by telephone, or by electronic means. If the clinician has any concerns about the gestation of the pregnancy during a telephone or electronic consultation, the woman will be asked to attend a clinic.
In June 2025, the House of Commons voted to add a clause to the Crime and Policing Bill which would decriminalise abortion for a woman acting in relation to her own pregnancy. The bill will now progress through Parliament in the usual way and is currently being debated in the House of Lords. Should abortion be decriminalised for a woman acting in relation to her own pregnancy these offences would still apply to medical professionals and third parties who do not abide by the rules set out in the Abortion Act 1967.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what is the estimated cost of strikes within the NHS in the past six months; and what new proposals are being considered to protect patient services during any further strikes.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The five-day resident doctor strike in July 2025 had an estimated cost to the National Health Service of approximately £240 million, and this is a starting estimate for the planned November strike. The costs were lower than in July 2024 as a result of lower turnout. We continue to update estimates as new data becomes available, in line with receiving business as usual financial data from NHS systems.
The NHS has tried and tested plans in place to minimise disruption and will work with partners to ensure that safe care for patients continues to be available and emergency services continue to operate. Data published on 23 November shows that the NHS met its ambitious goal to maintain 95% of planned care during the November round of strike action, surpassing the 93% protected during action in July, while still maintaining critical services, including maternity services and urgent cancer care.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure that those who are unwell can secure an appointment with their general practitioner.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is determined to work with the National Health Service to fix the front door of our health service and ensure that everyone who is unwell can access general practice (GP) appointments and services. Through our 10-Year Health Plan, it will be easier and faster to see a GP. The 8:00am scramble will end, we will train more doctors, and we will guarantee digital consultations within 24 hours.
In October 2024, we invested £82 million into the Additional Roles Reimbursement Scheme to support the recruitment of 1,900 individual GPs into primary care networks across England, helping to increase appointment availability and improve care for thousands of patients. We have also delivered the biggest boost to GP funding in years, an £889 million uplift, with GPs now receiving a growing share of NHS resources. The new £102 million Primary Care Utilisation and Modernisation Fund will create additional clinical space within over 1,000 practices across England. This investment will deliver more appointments and improve patient care.
Health is a devolved matter in Northern Ireland, and responsibility for GP services lies with the Northern Ireland Executive and at Stormont.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they will take to protect patients during the planned strike by resident doctors in England in July.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The priority is to keep patients as safe as possible during any industrial action. The National Health Service makes every effort through rigorous contingency planning to minimise disruptions and their impact on patients and the public during industrial action.
The NHS works hard to prioritise resources to protect emergency treatment, critical care, neonatal care, maternity, and trauma, and to ensure that patients who have waited the longest for elective care and cancer surgery are prioritised.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether there are any serious side effects from taking weight-loss drugs, including Wegovy and Mounjaro; and if so, whether those side effects have been made public.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of all medicines, including weight loss drugs, such as Wegovy (semaglutide) and Mounjaro (tirzepatide), which belong to a group of medicines known as the GLP-1 receptor agonists.
Patient safety is our top priority and no medicine would be approved unless it met our expected standards of safety, quality, and effectiveness. We have robust safety monitoring and surveillance systems in place, and when a safety issue is confirmed, we always act promptly to inform patients and healthcare professionals, and take appropriate steps to mitigate any identified risk.
Importantly, these medicines have been assessed to be safe and effective when used for their licensed indications. This means that if patients have been properly prescribed this by a healthcare professional following a consultation for a medical condition that these medicines are approved to treat, then they should be reassured that the benefits will outweigh risks of taking them.
Like all medicines, GLP-1 receptor agonists can cause side effects. All known side effects for these medicines, including serious side effects, are made publicly available through the Product Information. This is issued at the time of licensing, and is updated as any new side effects are identified. This includes the Summary of Product Characteristics, which is intended for healthcare professionals, and the Patient Information Leaflet, which is provided to patients. These documents are published on the products section of the MHRA website.
In addition, members of the public and healthcare professionals can access anonymised data on suspected side effects reported to the Yellow Card scheme via the interactive Drug Analysis Profiles platform. This ensures full transparency and enables anyone to view the types and numbers of suspected adverse reactions reported for a particular medicine.
Some of the most common side effects are gastrointestinal effects, such as nausea, vomiting, and diarrhoea. These side effects were observed in clinical trials and make up the majority of Yellow Card reports we receive. Most side effects are mild to moderate in severity or short in duration, but in some cases, they may lead to complications, such as severe dehydration resulting in the need to go to hospital for treatment.
Although infrequent, inflammation of the pancreas, known as acute pancreatitis, has also been reported. This can be serious. The main symptom is severe pain in the stomach that radiates to the back and does not go away. Anyone who experiences this should seek immediate medical help and report the reaction to the MHRA’s Yellow Card scheme.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many nurses have been trained in England in each of the past three years.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Higher Education Statistics Agency publishes data on the number of students qualifying from higher education courses in the United Kingdom, and this includes information on a broad ranges of undergraduate nursing courses. The published data is not detailed enough to allow for the reliable identification of all students completing courses which specifically lead to registered nursing status.
As a proxy for the number of students completing nursing courses each year, the Nursing and Midwifery Council (NMC) publish information on the number of UK trained nurses joining their register for the first time, who are resident in England.
The following table shows the number of UK trained nurses joining the NMC register in England for the first time by financial year:
Financial year | Number of UK qualified registered nurses joining the NMC register for the first time |
2022/23 | 16,420 |
2023/24 | 18,478 |
2024/25 | 19,670 |
Source: Nursing and Midwifery Council, March 2025 Annual Data Report.
Asked by: Lord McCrea of Magherafelt and Cookstown (Democratic Unionist Party - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they have plans to increase protections to the lives of unborn children.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Existing criminal offences relating to foetuses are contained in the Offences Against the Person Act 1861 and the Infant Life Preservation Act 1929. The Government has no plans to change these.